Jounce Therapeutics, Inc. EBITDA 2017-2022 | JNCE
Jounce Therapeutics, Inc. ebitda from 2017 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Jounce Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-49 |
| 2021 | $-87 |
| 2020 | $-42 |
| 2019 | $55 |
| 2018 | $-29 |
| 2017 | $-14 |
| 2016 | $-12 |
| 2015 | $-29 |
| 2014 | $-15 |
| Jounce Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-31 |
| 2022-09-30 | $-31 |
| 2022-06-30 | $-33 |
| 2022-03-31 | $-37 |
| 2021-12-31 | $-29 |
| 2021-09-30 | $-29 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-26 |
| 2020-12-31 | $-26 |
| 2020-09-30 | $-24 |
| 2020-06-30 | $-27 |
| 2020-03-31 | $-26 |
| 2019-12-31 | $-23 |
| 2019-09-30 | $98 |
| 2019-06-30 | $-7 |
| 2019-03-31 | $-13 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-8 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-13 |
| 2017-12-31 | $-10 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $6 |
| 2016-09-30 | $4 |
| 2016-06-30 | $-12 |
| 2016-03-31 | $-10 |
